Header Logo

Connection

HARIS ZAHOOR to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications HARIS ZAHOOR has written about Protein Kinase Inhibitors.
HARIS ZAHOOR
Connection Strength
0.425
Protein Kinase Inhibitors
  1. Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer. Invest New Drugs. 2019 12; 37(6):1231-1238.
    View in: PubMed
    Score: 0.425
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.